The United States Influenza Vaccines market size was valued at USD 4.78 Billion in 2024 and is expected to grow USD 9.66 Billion in 2033 at a compound annual growth rate (CAGR) of 8% from 2025 to 2033.
The influenza vaccines market in the United States was valued at US$ 3,962 billion in 2022 and is expected to reach US$ 8,347 billion by 2031, registering a CAGR of 8.6% during the forecast period.
